The study was aimed to screen out miRNAs with differential expression in hepatocellular carcinoma (HCC), and to explore the influence of the expressions of these miRNAs and their target gene on HCC cell proliferation, invasion and apoptosis. MiRNAs with differential expression in HCC were screened out by microarray analysis. The common target gene of these miRNAs (miR-139-5p, miR-940 and miR-193a-5p 
epithelial-mesenchymal transition (EMT) and metastasis, and its down-regulation is observed in HCC cells. 8 Li et al revealed the positive correlation between miR-139 down-regulation and poor HCC prognosis. 9 Meanwhile, miR-940 and miR-193a-5p have also been demonstrated to be remarkably down-regulated in HCC tissues 10, 11 .
MiR-940 suppresses tumour cell invasion and migration through regulating chemokine CXCR2, 12 while miR-193a decreases proliferation and increased apoptosis of HCC cells as well as improved the effect of sorafenib therapy. 13 MiR-193b increased cisplatin sensitivity of HCC cells and induced apoptosis. 14 These previous studies suggest that miR-139, miR-940 and miR-193 play negative roles in HCC development.
Cysteine-rich acidic secreted protein/osteonectin, cwcv, and kazal-like domains proteoglycan 1 (SPOCK1), the gene that encodes the protein core of a seminal plasma proteoglycan, is an oncogene that involves in cell-cycle control, apoptosis, DNA repair and metastasis. 15 According to Li et al's study, SPOCK1 is able to block apoptosis and promote metastasis in HCC. 16 Its promotive effect was also found in various human malignancies, such as breast cancer, 17 colorectal cancer, 18 prostate cancer 18 and ovarian cancer. 19 Yan et al investigated the relationship between miR-129-5p and SPOCK1
and pointed out that SPOCK1 can be regulated by miR-129-5p in gastric cancer, and the suppression of SPOCK1 inhibits cancer deterioration. 20 Therefore, overexpression of SPOCK1 is adverse to cancer treatment. Since there are few researches at present to investigate the functions of SPOCK1 in HCC, further studies about SPOCK1 and its upstream regulators are essential.
In this study, the expression levels of miR-139-5p, miR-940 and miR-193a-5p in HCC were investigated and their biological functions were explored. The target relationships between these miRNAs and SPOCK1 were also investigated to uncover the mechanisms that underlie miRNAs' influence on HCC development. The results could provide novel insights into potential molecular targets for HCC treatment. Table 1 .
| MATERIALS AND METHODS

| Patient samples
T A B L E 1 Clinical and pathologic characteristics of 46 patients with HCC
Characteristics miR-139-5p high miR-139-5p low P value miR-139-5p high miR-139-5p low P value miR-139-5p high miR-139-5p low P value n = 10 n = 36 n = 9 n = 37 n = 7 n = 39 
| Microarray analysis
The transcriptome profiles of 16 liver specimens, including nine specimens from the tumour area (HCC) and seven specimens from normal liver (NL) of patients who underwent hepatic resection, were determined using the Affymetrix Human miRNA Array 2.0 (HTA 2.0) 
| Kaplan-Meier survival analysis
The mRNA/miRNA normalized gene expression data and clinical information of 377 liver hepatocellular carcinoma (LIHC) samples were obtained from the Cancer Genome Atlas (TCGA) database (https://por tal.gdc.cancer.gov/projects/TCGA-LIHC). These patients were divided into two groups according to the median value of expression level of three selected miRNAs and SPOCK1. All the data were applied to perform Kaplan-Meier survival analysis and log-rank statistics. Hazard ratio (HR) and 95% CI of the association between SPOCK1/miRNAs and overall survival were calculated using Cox proportional hazards analysis with R "Survival", "Survplot", and "Kmplot" packages.
| Cell line and transfection
The HCC cell line HepG2, Hep3b and NL cell line HL-7702 were purchased from BeNa Culture Collection (Beijing, China PmirGLO, miRNA mimics and NC were all obtained from Promega.
| RNA pull-down assay
RNA structure buffer (100 μL) was used to incubate biotin-labelled The microplate reader was used to measure absorbance at 490 nm. The number of invaded cells was counted by microscope.
| MTT assay
| Transwell assay
| Cell apoptosis
Cells harvested after 48 hours transfection were stained by PI Annexin V Apoptosis Detection kit (BD Bioscience) and then detected by FACS Calibur flow cytometry (BD Bioscience) to determine apoptosis. Data analysis was performed by FACS Diva software.
| Tumour formation in vivo
Six 8-week-old male BALB/c-nude mice per group were used for this experiment. HepG2 cell suspension was prepared using logarithmic phase cells. The miR-139-5p, miR-940 and miR-193a-5p mature sequences were first cloned after the cytomegalovirus promoter into the pcDNA3.1 vector. Then, the vectors were transfected into HepG2 cells as mentioned previously for G418 (Geneticin) selection.
The suspension was subcutaneously injected into the back of nude mice (2 × 10 6 cells per mouse) after selection. The mice were killed after 4 weeks and the tumour weights were measured. The tumour volumes were calculated every week by the formula S = 1/2 × ab 2 (a is tumour length and b is tumour width). All animal experiments were approved by the First Affiliated Hospital of Guangzhou University of Chinese Medicine.
| Western blot
Tumour tissues obtained from killed nude mice were grinded into powder in liquid nitrogen with RIPA buffer (Solarbio, Beijing, China).
Total proteins in tissue were extracted by protein extraction kit (Millipore, Billerica, MA, USA) separated by electrophoresis on 10% SDS-PAGE. After transferring the protein onto polyvinylidene fluoride membrane (Invitrogen), the membrane was in turn incubated with primary antibody overnight at 4°C and secondary antibody for 1 hour.
The primary antibodies were rabbit anti-human antibodies: anti-SPOCK1 (1:2000, ab229935), anti-Ki67 (1:1000, ab92742), anti-caspase 3 (1:500, ab13847), anti-caspase 7 (1 µg/mL, ab69540), anti-caspase 8 (1 µg/mL, ab25901), anti-E Cadherin (1:500, ab15148), anti-E Cadherin (1:500, ab15148), anti-N Cadherin (1 µg/mL, ab18203), antiVimentin (1 µg/mL, ab45939) and anti-GAPDH (1:2500, ab9485) and mouse anti-human antibodies: anti-PCNA (1 µg/mL, ab29) and anti-GAPDH (1 µg/mL, ab9484) and the secondary antibody was goat anti-rabbit IgG-HRP (1:10000, ab6721) and goat anti-mouse IgG-HRP
(1:5000, ab6789). The antibodies used were purchased from Abcam (Cambridge, MA, USA). Electrochemiluminescent (ECL) Detection System (Thermo Scientific) was used for signal detection.
| Statistics
All statistical analyses were performed using GraphPad Prism 6.0.
Data were expressed as mean ± SD. Student's t test and one-way ANOVA were used to compare the significance between two groups and among multiple groups respectively. Two-sided P values were calculated, and P < 0.05 was chosen for statistical significance. All experiments were repeated for at least three times.
| RESULTS
| MiR-139-5p, miR-940 and miR-193a-5p were down-regulated in HCC tissues and HepG2 cell
MiRNAs with differential expression (fold change > 2, P < 0.05) in HCC tissues were screened out ( Figure 1A ). MiR-139-5p, miR-940
and miR-193a-5p were found to target multiple common genes in human cancers, which could affect cancer development, thus were chosen as the miRNAs of interest in this study. 
139-5p, miR-940 and miR-193a-5p
The possible target genes of miR-139-5p, miR-940 and miR-193-5p
were predicted by Targetscan database. Among them, 11 common target genes were screened out through the analysis of the potential target genes profile ( Figure 4A ). Then, we used another two databases, starBase v2.0 and microRNA.org, to verify our prediction. By literature review, we have confirmed four predicted common target genes, SPOCK1, GDE1, TRAF3 and TAOK1, that were frequently found associated with tumourigenesis. We then conducted RNA pull-down assay to determine the binding relationship between the three miRNAs and the four genes. Although all of them were predicted to be able to bind to miR-139-5, miR-940 and miR-193a-5p
( Figure 4B ), only SPOCK1 had strong binding capacity with all three selected miRNAs ( Figure 4C ). In 46 pairs HCC tissues, SPOCK1 mRNA and protein expressions were also distinctively elevated (Figure 4D,E) . In addition, the mRNA and protein expression levels of SPOCK1 were also higher in HepG2 and Hep3b cells ( Figure 4F ,G).
After miR-139-5p/miR-940/miR-193a-5p was overexpressed, the level of SPOCK1 was restrained than NC group both in mRNA and protein expression. However, in cotransfection group, the expression of SPOCK1 mRNA and protein was lower than those in single miRNA mimics group, but the difference was not significant (Figure 4H,I ). The SPOCK1 high expression group had a significantly poorer overall survival by Kaplan-Meier analysis ( Figure 4J ). We supposed that these miRNAs have other target mRNAs which are tumour promoter and overexpression of these miRNAs inhibits these mRNAs the expression of these mRNAs leading to a better antitu- Figure 8G ). Moreover, Western blot was . (B) SPOCK1, GDE1 , TRAF3 and TAOK1 were common target genes of miR-139-5p, miR-940 and miR-193a-5p. C, According to RNA pull-down assay, the three selected miRNAs expressions of Bio-SPOCK1 probes were all increased. *P < 0.05 compared with Bio-NC-probe. D, The relative mRNA expression of SPOCK1 detected by qRT-PCR was higher in HCC tissues. **P < 0.01 compared with normal tissues. E, The relative protein expression of SPOCK1 detected by western blot was higher in HCC tissues. **P < 0.01 compared with normal tissues. F, The relative mRNA expression of SPOCK1 detected by qRT-PCR was higher in HepG2 and Hep3b cell lines. **P < 0.01 compared with normal HL-1107 cell line. G, The relative protein expression of SPOCK1 detected by western blot was higher in HepG2 and Hep3b cell lines. **P < 0.01 compared with normal HL-1107 cell line. H, The relative mRNA expression of SPOCK1 detected by qRT-PCR was reduced after overexpression of miR-139-5p/miR-940/miR-193a-5p.*P < 0.05, **P < 0.01 compared with NC group. I, The relative protein expression of SPOCK1 detected by western blot was reduced after overexpression of miR-139-5p/miR-940/ miR-193a-5p. *P < 0.05, **P < 0.01 compared with NC group. J, Kaplan-Meier curve analysis of overall patient survival between those with high SPOCK1 expression and low SPOCK1 expression in the TCGA-LIHC database.
used to examined the key cell apoptosis regulators and found that miR-139-5p/miR-940/miR-193a-5p mimic enhanced the protein expression of the active forms of caspase 3, caspase 7 and caspase 8 in the tumour tissues ( Figure 8H) . Therefore, the results indicated that miR-139-5p, miR-940 and miR-193a-5p inhibited tumour growth in vivo through down-regulating the expression of SPOCK1.
| DISCUSSION
Down-regulation of miR-139-5p, miR-940 and miR-193a-5p was identified in HCC, and the inhibitory influence of these miRNAs imposed on HCC progression was revealed in this study. SPOCK1, the common target gene of miR-139-5p, miR940 and miR-193a-5p, enhanced HCC cell viability and invasion. Therefore, the regulatory Similarly, miR-193b also facilitated sorafenib and cisplatin induced apoptosis, 14, 24 indicating that miR-193 could improve chemosensitivity. In summary, the antitumour effect of miR-139-5p has been reported in many researches. Our study confirmed its inhibitory study showed that SPOCK1 could inhibit apoptosis and promote cancer invasion. 16 Meanwhile, SPOCK1 also played promotive roles in the progression of other cancers, 25 so that it was considered as a novel metastasis biomarker and potential target. 26 Many studies
showed that SPOCK1 could activate PI3K/AKT signalling pathway, leading to the promotion of gliomas, 27 colorectal cancer 18 and gall bladder cancer. 28 In gastric cancer, miR-129-5p could inhibit the expression of SPOCK1, leading to the suppression of cancer cell processes. 20 Nonetheless, the target relationship between SPOCK1
and three miRNAs has not been properly investigated before. We found that SPOCK1 could bind miR-139-5p, miR-940 and miR193a-5p, and it was suppressed by these miRNAs directly and specifically in HCC cells. This finding might be one of the potential mechanisms in inhibiting HCC development. As a common target gene of these miRNAs, SPOCK1 played a vital role in stimulating HCC progression and had great potential to be a novel target for HCC treatment.
However, there still existed several limitations in our study. The sample size in our study is small and the relationships among these miRNAs need further exploration. In addition, we found that 
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